Biomind Labs Stock Market Value
| BMNDF Stock | USD 0.11 0.02 22.77% |
| Symbol | Biomind |
Biomind Labs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biomind Labs' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biomind Labs.
| 06/28/2025 |
| 12/25/2025 |
If you would invest 0.00 in Biomind Labs on June 28, 2025 and sell it all today you would earn a total of 0.00 from holding Biomind Labs or generate 0.0% return on investment in Biomind Labs over 180 days. Biomind Labs is related to or competes with Chia Tai, International Stem, Vaccinex, Medigene, and Biora Therapeutics. Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nano... More
Biomind Labs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biomind Labs' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biomind Labs upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1291 | |||
| Maximum Drawdown | 443.04 |
Biomind Labs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biomind Labs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biomind Labs' standard deviation. In reality, there are many statistical measures that can use Biomind Labs historical prices to predict the future Biomind Labs' volatility.| Risk Adjusted Performance | 0.1018 | |||
| Jensen Alpha | 6.79 | |||
| Total Risk Alpha | 1.67 | |||
| Treynor Ratio | 1.56 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biomind Labs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biomind Labs Backtested Returns
Biomind Labs is out of control given 3 months investment horizon. Biomind Labs secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. We were able to break down nineteen different technical indicators, which can help you to evaluate if expected returns of 7.35% are justified by taking the suggested risk. Use Biomind Labs Risk Adjusted Performance of 0.1018, mean deviation of 13.68, and Standard Deviation of 54.56 to evaluate company specific risk that cannot be diversified away. Biomind Labs holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 4.57, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biomind Labs will likely underperform. Use Biomind Labs total risk alpha, as well as the relationship between the daily balance of power and day typical price , to analyze future returns on Biomind Labs.
Auto-correlation | -0.3 |
Weak reverse predictability
Biomind Labs has weak reverse predictability. Overlapping area represents the amount of predictability between Biomind Labs time series from 28th of June 2025 to 26th of September 2025 and 26th of September 2025 to 25th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biomind Labs price movement. The serial correlation of -0.3 indicates that nearly 30.0% of current Biomind Labs price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.3 | |
| Spearman Rank Test | -0.5 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Biomind Labs lagged returns against current returns
Autocorrelation, which is Biomind Labs pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biomind Labs' pink sheet expected returns. We can calculate the autocorrelation of Biomind Labs returns to help us make a trade decision. For example, suppose you find that Biomind Labs has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Biomind Labs regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biomind Labs pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biomind Labs pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biomind Labs pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Biomind Labs Lagged Returns
When evaluating Biomind Labs' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biomind Labs pink sheet have on its future price. Biomind Labs autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biomind Labs autocorrelation shows the relationship between Biomind Labs pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Biomind Labs.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Biomind Pink Sheet
Biomind Labs financial ratios help investors to determine whether Biomind Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biomind with respect to the benefits of owning Biomind Labs security.